This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
If you read my article on using Autohotkey for radiology , I describe that I use a click-lock script to simulate holding down the left mouse button. This allows me to power-scroll by using a single keystroke (in my case, backslash) to toggle scrolling on/off instead of needing to hold the mouse in a death grip for hours a day (which is a great way to destroy your wrist): ;toggle holding down the left mouse button :: alt := not alt if (alt) { Click Down } else { Click Up } Return If you also happ
Radiotherapy developer Actinium Pharmaceuticals is launching ATNM-400, a novel, non-prostate-specific membrane antigen (PSMA) targeting radiotherapy for prostate cancer that uses the actinium-225 (Ac-225) radioisotope. Initial preclinical data from a study on ATNM-400's performance will be presented at the American Association for Cancer Research (AACR) annual meeting being held between April 25 and 30 inChicago.This presentation will share results from in vitro and in vivo studies, including bi
GE HealthCare plans to launch its Flyrcado (flurpiridaz F-18) injection in the U.S. at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo to be held March 29 to 31inChicago, IL. The company received approval from the U.S. Food and Drug Administration (FDA) for the injection in 2024.Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The board of governors of the American Institute of Ultrasound in Medicine (AIUM), along with its executive committee, has named the 2025 class of AIUM fellows. Individuals must be nominated, meet eligibility criteria, complete an application, and secure letters of support to be considered Fellows. The AIUM executive committee reviews these materials and sends successful applications to the AIUM board of governors for final approval.
The board of governors of the American Institute of Ultrasound in Medicine (AIUM), along with its executive committee, has named the 2025 class of AIUM fellows. Individuals must be nominated, meet eligibility criteria, complete an application, and secure letters of support to be considered Fellows. The AIUM executive committee reviews these materials and sends successful applications to the AIUM board of governors for final approval.
Though rare, some reactions can be life-threatening, making the understanding of how to appropriately manage them a critical aspect of a technologist's responsibilities.
GE HealthCare plans to launch its Flyrcado (flurpiridaz F-18) injection in the U.S. at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo to be held March 29 to 31inChicago, IL. The company received approval from the U.S. Food and Drug Administration (FDA) for the injection in 2024.Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
An F-18 FDG-PET/CT scan proved crucial in identifying an ultrarare case of brain inflammation in a patient due to the flu, a team at Zibo Central Hospital in Zibo, China, has reported. The patient was a 38-year-old woman who presented to the emergency department with a six-day fever, headache, and severe fatigue, and her brain and spinal cord MRI showed no abnormalities, reported nuclear medicine physician Hukui Sun, MD, and colleagues.
The number of machine learning- and AI-powered medical devices approved by the U.S. Food and Drug Administration (FDA) has increased significantly in recent years. In 2024, the FDA approved nearly 1,000 AI medical devices compared to just 221 in 2023. The increase could transform the healthcare industry by giving practitioners access to more diagnostics and treatment options that lead to better patient outcomes.
AI could help sonographers find fetal abnormalities faster without sacrificing diagnostic quality, according to research published March 27 in the New England Journal of Medicine. A team led by Thomas Day, PhD, from Kings College London in England, found that AI sped up scan times by more than eight minutes and achieved high marks in detecting fetal malformations.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter. Under the agreement, Varian will immediately begin selling the image-guided arterial embolization tool in the U.S. The Sniper Balloon Occlusion Microcatheter has a pressure-directed balloon system for occlusion in the peripheral vasculature.
Adding thoracic aortic calcification (TAC) data to coronary artery calcification (CAC) AI models shows promise as a risk prediction biomarker for CAC in asymptomatic patients undergoing chest CT, researchers have reported. The findings could help clinicians better understand the possible prognostic function of TAC, according to a team led by Young Joo Suh, MD, PhD, of Yonsei University College of Medicine in Seoul, South Korea.
Key Points: Weight Bearing CT (WBCT) allows for bilateral comparative data that is imperative when diagnosing ankle syndesmosis. Side-to-side volume differences of 19% or greater may be indicative of an abnormality. Gender norms are important to consider when evaluating ankle syndesmosis. The ankle syndesmosis is stabilized by a complex of ligaments, including the anterior inferior tibiofibular ligament, posterior inferior tibiofibular ligament, and the interosseous ligament and membrane.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Ascend Learning has acquired online diagnostic imaging education provider Clover Learning, which Ascend said will add to its portfolio of training and certification offerings to healthcare professionals. Clover Learning uses evidence-based learning methodologies and interactive tools for its online diagnostic imaging market training, certification exam preparation, and continuing education courses.
Researchers have discovered a groundbreaking use of terahertz (THz) imaging to visualize cochlear structures in mice, offering non-invasive, high-resolution diagnostics. By creating 3D reconstructions, this technology opens new possibilities for diagnosing hearing loss and other conditions. THz imaging could lead to miniaturized devices, like THz endoscopes and otoscopes, revolutionizing diagnostics for hearing loss, cancer, and more.
A Society of Interventional Radiology and Society of Abdominal Radiology survey has found that while 84% of participants say reviewing biopsy pathology findings for concordance with imaging should be standard practice, only 57% say they routinely do so. In a letter published in the Journal of Vascular and Interventional Radiology , Olga Brook, MD, of Beth Israel Deaconess Medical Center in Boston and colleagues underscored the utility of reviewing biopsy reports for concordance, especially in in
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Amy Acuna and the radiology team she leads welcomed patients to the new UCSF Health Peninsula Outpatient Center (POPC) in downtown Burlingame on Monday, February 24, expanding access for patients living on the Peninsula.
With increasing demand for efficiency in healthcare, and the potential for AI to reduce misdiagnoses the third leading cause of death in the U.S. the industry is at a crucial inflection point. In a recent Crossroads by Alantra podcast, Elad Walach, CEO of Aidoc, shared his perspectives on how the company is reshaping the clinical AI landscape, from its early days in radiology to becoming a comprehensive AI platform driving real-world impact in hospitals worldwide.
Discover Unmatched MRI Image Quality and Speed with the Grand Unveiling of Subtle-ELITE, Subtle Medicals Most Powerful Innovation Yet Subtle Medical - Aunt Minnie March 19, 2025 Webinar Outline Imaging providers are constantly looking for ways to enhance efficiency while balancing patient care, sustainability, and financial growth. As the global leader in AI-powered image [.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
173 
Let's personalize your content